CN ETF

Mavorixafor durably and meaningfully elevated participants' mean absolute neutrophil counts (ANC) Mavorixafor enabled substantial reductions in G-CSF dosing while maintaining  mean ANC at normal levels Phase 2 study results and new analysis confirming functionality of neutrophils in sub-study participants bolster confidence in achieving success in Phase 3 4WARD trial Company conference call and webcast today at 8:00 am ET BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced positive new clinical data from its now completed Phase 2 clinical trial evaluating mavorixafor, an oral CXCR4 antagonist, in the treatment of people with chronic neutropenia (CN). An analysis of final data from the six-month study showed that once-daily oral mavorixafor durably and meaningfully increased participants' mean absolute neutrophil counts (ANC).

VANCOUVER, BC / ACCESSWIRE / October 7, 2024 / Condor Resources Inc. ("Condor" or the "Company") (TSXV:CN) announces that, due to non-performance, the Company has terminated the agreement with Chakana Copper Corp. ("Chakana") that provided a framework for Chakana to acquire a 100% interest in the Company's Soledad concessions in Peru. Under the terms of the agreement initially executed in April 2017 and subsequently amended several times, Chakana was required to complete a US$1,000,000 cash payment and issue CAD$200,000 worth of Chakana common shares at a price not less than $0.145/share to Condor on June 23, 2024 and a further payment of US$ 1,400,000 by June 23, 2025 (the "Agreement").

100% of evaluable participants at Month 6 achieved target absolute neutrophil count (ANC) increase with once-daily, oral mavorixafor +/- stable-dose G-CSF as of the interim analysis data cut-off date

Soft consumer confidence and property-market woes are playing a large role in the slowdown of China's economy. We believe that recently unveiled measures to support the housing market are likely to only have modest effects on bolstering economic growth.

As of last Friday, the Chinese yuan depreciated to a 15-year low against the dollar, to close last week at 7.3640 ($0.1358) on the USDCNY exchange rate. The U.S. stock market generally has a negative correlation with the yuan, albeit not a perfect one.

Shares of Chinese germanium producers hit the daily upward limit early Tuesday on news that Beijing imposed export controls on gallium and germanium, two minerals critical to the production of semiconductors.

World equities were mostly higher Monday after President Joe Biden and House Speaker Kevin McCarthy reached a final agreement on a deal to raise the U.S. debt ceiling, though the measure requires approval by Congress.